Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Moleculin Biotech, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 2.15M | 2.98M | +825.3K (+38.3%) |
| Value | $8.74M | $10.9M | +$2.18M (+25.0%) |
New holders (9)
Institutions that held Moleculin Biotech, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 59,900 | $220.0K | 0.00% |
| XTX Topco Ltd | 32,997 | $121.0K | 0.04% |
| Gsa Capital Partners LLP | 31,120 | $114.0K | 0.01% |
| Goldman Sachs Group Inc | 25,707 | $94.0K | 0.00% |
| Virtu Financial LLC | 25,302 | $93.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 2,513 | $9.00K | 0.00% |
| UBS Group AG | 1,071 | $4.00K | 0.00% |
| Salem Investment Counselors Inc | 5 | $0 | 0.00% |
| Strategic Blueprint, LLC | 90 | $0 | 0.00% |
Sold out (6)
Institutions that held Moleculin Biotech, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Squarepoint Ops LLC | 28,904 | $118.0K |
| Two Sigma Securities, LLC | 27,224 | $111.0K |
| Cubist Systematic Strategies, LLC | 26,624 | $109.0K |
| Charles Schwab Investment Management Inc | 12,167 | $50.0K |
| Steward Partners Investment Advisory, LLC | 1,000 | $4.08K |
| Harel Insurance Investments & Financial Services Ltd. | 10,000 | – |